DX600 TFA is a potent and selective angiotensin-converting enzyme 2 (ACE2) inhibitor, exhibiting no activity against ACE. This tool compound is widely used in cardiovascular and SARS-CoV-2 research, facilitating both in vitro enzymatic assays and in vivo physiological studies of the renin-angiotensin system.